Miromatrix Medical Inc.
MIRODelisted Dec 13, 2023- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001527096
Miromatrix Medical Inc. was delisted on Dec 13, 2023; its insiders filed their last Form 4 on Dec 13, 2023; 32 institutions reported holding it in 13F filings for Q3 2023, worth $8.78M in total; no superinvestor held it.
13F holders, Q4 2021
Institutional positions in Miromatrix Medical Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 22
- +3 vs. Q3 2021
- Shares held
- 3.08M
- −73.1K (−2.3%) vs. Q3 2021
- Total value
- $14.5M
- −$7.51M (−34.2%) vs. Q3 2021
- New holders
- 6
- 8 more added
- Sold out
- 3
- 4 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MIRO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 32 | $8.78M |
| Q2 2023 | 32 | $11.6M |
| Q1 2023 | 31 | $11.1M |
| Q4 2022 | 28 | $11.2M |
| Q3 2022 | 22 | $15.4M |
| Q2 2022 | 22 | $12.9M |
| Q1 2022 | 21 | $12.6M |
| Q4 2021 | 22 | $14.5M |
| Q3 2021 | 19 | $22.0M |
| Q2 2021 | 21 | $39.1M |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Miromatrix Medical Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| G2 Investment Partners Management LLC | 684,978 | $3.21M | 0.55% | +5,008+0.7% | Added |
| First Light Asset Management, LLC | 488,092 | $2.29M | 0.16% | +13,092+2.8% | Added |
| Gagnon Securities LLC | 408,387 | $1.92M | 0.29% | −15,162−3.6% | Reduced |
| RTW Investments, LP | 280,000 | $1.31M | 0.02% | 00.0% | Unchanged |
| Polar Asset Management Partners Inc. | 250,451 | $1.18M | 0.01% | −49,549−16.5% | Reduced |
| Friess Associates LLC | 246,323 | $1.16M | 0.45% | 00.0% | Unchanged |
| Gagnon Advisors, LLC | 229,802 | $1.08M | 0.43% | 00.0% | Unchanged |
| Granite Point Capital Management, L.P. | 177,642 | $833.0K | 0.32% | 00.0% | Unchanged |
| Vanguard Group Inc | 154,376 | $724.0K | 0.00% | +154,376 | New |
| Cambridge Investment Research Advisors, Inc. | 36,400 | $171.0K | 0.00% | +36,400 | New |
| Perkins Capital Management Inc | 21,880 | $103.0K | 0.07% | −25,340−53.7% | Reduced |
| Renaissance Technologies LLC | 15,821 | $74.0K | 0.00% | +15,821 | New |
| Citadel Advisors LLC | 16,013 | $74.0K | 0.00% | +16,013 | New |
| BlackRock Inc. | 15,181 | $71.0K | 0.00% | +395+2.7% | Added |
| Jane Street Group, LLC | 12,212 | $57.0K | 0.00% | −11,271−48.0% | Reduced |
| Geode Capital Management, LLC | 11,810 | $54.0K | 0.00% | +1,607+15.8% | Added |
| Royal Bank of Canada | 10,000 | $47.0K | 0.00% | +8,000+400.0% | Added |
| US Bancorp | 10,000 | $47.0K | 0.00% | +10,000 | New |
| Sweet Financial Partners, LLC | 10,000 | $47.0K | 0.02% | +10,000 | New |
| Tower Research Capital LLC (TRC) | 2,585 | $12.0K | 0.00% | +1,276+97.5% | Added |
| UBS Group AG | 352 | $2.00K | 0.00% | +227+181.6% | Added |
| Wells Fargo & Company | 41 | $0 | 0.00% | +12+41.4% | Added |
| AWM Investment Company, Inc. | 0 | $0 | 0.00% | −116,688−100.0% | Sold out |
| Manatuck Hill Partners, LLC | 0 | $0 | 0.00% | −83,042−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −44,315−100.0% | Sold out |